In VitroSelection for Different Mutational Patterns in the HIV-1 Reverse Transcriptase Using High and Low Selective Pressure of the Nonnucleoside Reverse Transcriptase Inhibitor HBY 097
- 1 April 1997
- Vol. 231 (1), 112-118
- https://doi.org/10.1006/viro.1997.8513
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Concomitant combination therapy for HIV infection preferable over sequential therapy with 3TC and non-nucleoside reverse transcriptase inhibitorsProceedings of the National Academy of Sciences, 1996
- Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants.Proceedings of the National Academy of Sciences, 1996
- Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replicationAntimicrobial Agents and Chemotherapy, 1995
- Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV InfectionsJournal of Medicinal Chemistry, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroupsAntiviral Research, 1995
- Mutational Analysis of Residue 190 of Human Immunodeficiency Virus Type 1 Reverse TranscriptaseVirology, 1994
- Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replicationAntimicrobial Agents and Chemotherapy, 1993
- A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.Proceedings of the National Academy of Sciences, 1993
- Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinonesJournal of Medicinal Chemistry, 1991